Inhaled insulin and the dream of a needle-free insulin application

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 6, 2004, Pages 285-287

  Schatz, Helmut ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FUMARIC ACID DERIVATIVE; GLIBENCLAMIDE; HEMOGLOBIN A1C; IMMUNOGLOBULIN G ANTIBODY; INSULIN; INSULIN ANTIBODY; INSULIN TECHNOSPHERES; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

CLINICAL TRIAL; COUGHING; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; EDITORIAL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MONOTHERAPY; NEEDLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PASSIVE SMOKING; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; CLINICAL TRIALS; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HISTORY, 20TH CENTURY; HUMANS; INSULIN; LUNG;

EID: 3042723892     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-821018     Document Type: Editorial

References (9)

1. Bott S, Heinemann L, Rave K, Willavize SA, Carroll RS, Gruber S, Lee JD, Heise T. Time-action profile of an inhaled insulin preparation in comparison to insulin lispro and regular insulin. Diabetologia 2000; 43 (Suppl 1): A 46
2. Cefalu WT, Skyler JS, Kourides IA, Landschulz WH, Balagdas CC, Cheng S-L, Gelfand RA. Inhaled human insulin treatment in patients with type 2 diabetes mellitus. Ann Intern Med 2001; 134: 203-207
3. Gänsslen M. Über Inhalation von Insulin. Klin Wochenschr 1925; 4: 71
4. Heubner W, de Jongh SE, Laquer E. Über Inhalation von Insulin. Klin Wochenschr 1924; 3: 2342-2343
5. Mudaliar S, Henry RR, Fryburg DA, Becker RHA, Willavize SA, Fisher JM, Fountaine R, Sha S. Within-subject variability of inhaled insulin (Exubera®) versus subcutaneous regular insulin in elderly obese patients with type 2 diabetes mellitus. Diabetologia 2003; 46 (Suppl 2): A 277-A 278
6. Skyler SA, Cefalu WT, Kourides IA, Landschulz WH, Balagdas CC, Cheng S-L, Gelfand RA for The Inhaled Insulin Phase II Study Group. Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomized proof-of-concept study. Lancet 2001: 357: 331-335
7. Testa MA, Turner RR, Hayes JF, Scranton RE, Simonson DC. Satisfaction and quality of life with sulfonylurea plus either Metformin or Exubera®: an international randomized Phase 3 Trial. 64th ADA Congress, Orlando 2004, Abstract Number 487-P
8. Testa MA, Hayes JF, Turner RR, Simonson DC. Quality of life improvements in type 2 Diabete when Exubera® is added after failure on metformin monotherapy: an international randomized phase 3 trial. 64th ADA Congress, Orlando 2004, Abstract Number 1831-P
9. Weiss SR, Cheng S-L, Kourides IA, Gelfand RA, Landschulz WH, for the Inhaled Insulin Phase II Study Group. Inhaled insulin provides improved glycemia control in patients with type 2 diabetes mellitus inadequately controlled with oral agents. A randomized controlled trial. Arch Intern Med 2003; 163: 2277-2282